During the past decade, Illinois CancerCare-Galesburg conducted 207 clinical trials. In the 10-year time frame, 207 clinical trials started and 171 clinical trials were completed, i.e. on average, 82.6% percent of trials that started reached the finish line to date. In the past 5 years, 97 clinical trials started and 88 clinical trials were completed. i.e. 90.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Illinois CancerCare-Galesburg" #1 sponsor was "National Cancer Institute (NCI)" with 174 trials, followed by "Alliance for Clinical Trials in Oncology" with 67 trials sponsored, "SWOG Cancer Research Network" with 57 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 26 trials sponsored and "NRG Oncology" with 26 trials sponsored. Other sponsors include 28 different institutions and companies that sponsored additional 17 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Illinois CancerCare-Galesburg" #1 collaborator was "National Cancer Institute (NCI)" with 185 trials as a collaborator, "NRG Oncology" with 29 trials as a collaborator, "Canadian Cancer Trials Group" with 12 trials as a collaborator, "Cancer and Leukemia Group B" with 8 trials as a collaborator and "NCIC Clinical Trials Group" with 8 trials as a collaborator. Other collaborators include 57 different institutions and companies that were collaborators in the rest 44 trials.

According to Clinical.Site data, the most researched conditions in "Illinois CancerCare-Galesburg" are "Breast Cancer" (13 trials), "Recurrent Breast Carcinoma" (12 trials), "Stage IV Lung Cancer AJCC v8" (11 trials), "Invasive Breast Carcinoma" (10 trials) and "Recurrent Ovarian Carcinoma" (10 trials). Many other conditions were trialed in "Illinois CancerCare-Galesburg" in a lesser frequency.

Most popular intervention types in "Illinois CancerCare-Galesburg" are "Drug" (295 trials), "Other" (216 trials), "Biological" (141 trials), "Procedure" (87 trials) and "Radiation" (53 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (105 trials), "Quality-of-Life Assessment" (84 trials), "Questionnaire Administration" (55 trials), "Computed Tomography" (42 trials) and "Biospecimen Collection" (40 trials). Other intervention names were less common.

The vast majority of trials in "Illinois CancerCare-Galesburg" are 299 trials for "All" genders, 53 trials for "Female" genders and 13 trials for "Male" genders.

Currently, there are NaN active trials in "Illinois CancerCare-Galesburg". undefined are not yet recruiting, 91 are recruiting, 144 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 99 completed trials in Illinois CancerCare-Galesburg, 9 suspended trials, and 19 terminated clinical trials to date.

Out of the total trials that were conducted in Illinois CancerCare-Galesburg, 20 "Phase 1" clinical trials were conducted, 183 "Phase 2" clinical trials and 175 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 9 trials that are defined as “Not Applicable".